These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells. Joh T, Hosokawa Y, Suzuki R, Takahashi T, Seto M. Oncogene; 1999 Jan 28; 18(4):1125-30. PubMed ID: 10023690 [Abstract] [Full Text] [Related]
11. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells. Ono R, Masuya M, Nakajima H, Enomoto Y, Miyata E, Nakamura A, Ishii S, Suzuki K, Shibata-Minoshima F, Katayama N, Kitamura T, Nosaka T. Blood; 2013 Aug 15; 122(7):1271-83. PubMed ID: 23838347 [Abstract] [Full Text] [Related]
12. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A. Blood; 2000 Dec 01; 96(12):3887-93. PubMed ID: 11090074 [Abstract] [Full Text] [Related]
19. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells. Arai S, Yoshimi A, Shimabe M, Ichikawa M, Nakagawa M, Imai Y, Goyama S, Kurokawa M. Blood; 2011 Jun 09; 117(23):6304-14. PubMed ID: 21190993 [Abstract] [Full Text] [Related]
20. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. Blood; 2002 May 15; 99(10):3780-5. PubMed ID: 11986236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]